Category: Drug industry

11 12/6/2016

With media watchdogs on the sidelines, pharma-funded advocacy groups pushed Cures Act to the finish line  

1 11/29/2016

Off-label drug marketing: Who will decide what’s “truthful” when the evidence can’t be trusted?   

4 11/17/2016

The secret reasons why statins may not be as useful as we think

2 11/14/2016

Statins for everyone over 40? What patients need to think about before filling that prescription

10/27/2016

High stakes in ballot battle over rising prescription drug costs

10/25/2016

Black box warnings for ‘lifesaving’ hepatitis C drugs highlight systematic misinformation

3 9/28/2016

What some stories missed about the muscular dystrophy drug approval: Pharma’s close ties to vocal patient advocacy groups

4 9/7/2016

Seven intriguing angles on the EpiPen price-gouging story

8/30/2016

Where are the TV ads to “educate” patients about the negative Opdivo lung cancer trial?

8/23/2016

What journalists and consumers should know about the tug-of-war between biologics and generic ‘biosimilars’